Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form | Patent Number 11883494

US 11883494 B2
Application Number18186730
Publication NumberUS 20230248823 A1
Pendency10 months, 16 days
Filled DateMar 20, 2023
Priority DateNov 25, 2015
Publication DateAug 10, 2023
Expiration DateNov 24, 2035
Inventor/ApplicantsAnne Richter
Stefan Miltenyi
Andrew Kaiser
Michael Lutteropp
Mario Assenmacher
ExaminesJOHANSEN, PETER N.
Art Unit1644
Technology Center1600
Assignments
Miltenyi Biotec Gmbh
Current
Miltenyi Biotec Gmbh
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.